Combined Oxidative Phosphorylation Deficiency 3 (COXPD3)

Alias:
Fatal Mitochondrial Disease Due to Combined Oxidative Phosphorylation Defect Type 3
Coxpd3
Encephalomyopathy, Respiratory Failure, and Lactic Acidosis
Concentric Cardiomyopathy, Hypotonia, and Lactic Acidosis
Fatal Mitochondrial Disease Due to Coxpd3
Encephalomyopathy with Respiratory Failure and Lactic Acidosis
Encephalomyopathy Respiratory Failure and Lactic Acidosis
Concentric Cardiomyopathy Hypotonia and Lactic Acidosis
Combined Oxidative Phosphorylation Deficiency, Type 3
Favorite
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Combined Oxidative Phosphorylation Deficiency 3, also known as fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, is related to combined oxidative phosphorylation deficiency 4 and mitochondrial disease, and has symptoms including ataxia, seizures and tremor. An important gene associated with Combined Oxidative Phosphorylation Deficiency 3 is TSFM (Ts Translation Elongation Factor, Mitochondrial), and among its related pathways/superpathways are Metabolism of proteins and Peptide chain elongation. Affiliated tissues include brain, and related phenotypes are dilated cardiomyopathy and hypotonia
Related ID:

Basic Information

Inheritance
Age of Onset
Prevalence
Related Gene
Related Mouse Models
Reference
MALACARDS
AR
Newborn
<1/1000000
9
36
8

Medical Symptom

#
Categorization
Description
HPO Frequency
Orphanet Frequency
HPO Source Accession
No data available

Gene & Mutation

#
Gene
Function
Score
Mutations
No data available

Related Drugs

Name
CAS Number
Status
Phase
No data available

Disease Model

Category
Name
MGI
Related Gene
Strain of Origin
Publications
No data available

References Literature

Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Comparison
Al agent
Tutorials
Back to top